Clinical trials
Active, not recruiting Liver Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Eisai Inc. | 1 |
| Fifth Affiliated Hospital of Guangzhou Medical University | 1 |
| Guangxi Medical University | 1 |
| Harbin Medical University | 1 |
| Nanjing Sanhome Pharmaceutical, Co., Ltd. | 1 |
| The First Affiliated Hospital of Xiamen University | 1 |
| The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 9 |
| Carcinoma, Hepatocellular | 5 |
| Colorectal Neoplasms | 2 |
| Cholangiocarcinoma | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Neoplasms | 1 |
| Pain | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.